Critical care tele‐pharmacy services during COVID‐19 pandemic: A qualitative exploration of healthcare practitioners' perceptions

WHAT IS KNOWN AND OBJECTIVE: The scope of clinical pharmacy services has changed during COVID‐19 pandemic with the view to mitigating both exposure and spread of the virus. The performance of novel pandemic‐driven services such as tele‐pharmacy has remained unexplored, until now. The aim of this study is to investigate the perceptions of healthcare providers of the impact of tele‐pharmacy services provided in critical care units during COVID‐19. METHODS: A qualitative study of semi‐structured interviews conducted with healthcare practitioners who worked in COVID‐19 intensive care units and remotely interacted with clinical pharmacists at the Weill Cornell‐affiliated Hamad Medical Corporation, Doha, Qatar. Random sampling technique was employed to recruit participants, with the resultant interview guide piloted before commencement of data collection process. RESULTS AND DISCUSSION: From a total 129 and 200 physicians and nurses, respectively, 20 interviews were conducted with physicians (n = 15), and nurses (n = 5). From these interactions, a number of major themes emerged including: satisfactory understanding across clinical environment and personnel (physician and nurses) about remote clinical pharmacists' roles; additional robust feedback on the perception of the remote clinical pharmacy service; an understanding by ‘frontline’ health personnel on the discernible differences between remote and in‐person coverage of clinical pharmacists; a reflection by both physicians and nurses on the novel challenges involved in the implementation of such pandemic‐driven service; and solutions to overcome these challenges. WHAT IS NEW AND CONCLUSION: In this novel qualitative study of pandemic‐driven tele‐pharmacy service, we found a positive perception amongst healthcare practitioners towards this service; with residual challenges that will need further evaluation by large sampled sized surveys or mixed methods research.